Khuenl-Brady K S, Agoston S, Miller R D
Clinic for Anaesthesia, University of Innsbruck, Austria.
Acta Anaesthesiol Scand. 1992 Apr;36(3):260-3. doi: 10.1111/j.1399-6576.1992.tb03461.x.
The interaction of ORG 9426, a new non-depolarizing neuromuscular blocking agent, with intravenous anaesthetic drugs (fentanyl, thiopental, midazolam, droperidol and etomidate) has been investigated in cats. During an infusion of one of the above anaesthetics, the ED95 dose was determined by titration, and thereafter muscle relaxation was maintained with four subsequent doses of ORG 9426. Neither the potency nor the duration of action of the first dose nor that of the maintenance doses of ORG 9426 differed from those observed in a control group of cats anaesthetized with intraperitoneally administered pentobarbital. The recovery rates were similar in all groups. The authors conclude that, under the conditions of this study, commonly used intravenous anaesthetic drugs are not likely to influence the neuromuscular blocking potency and time course of action of ORG 9426 to any appreciable degree.
在猫身上研究了新型非去极化神经肌肉阻滞剂ORG 9426与静脉麻醉药(芬太尼、硫喷妥钠、咪达唑仑、氟哌利多和依托咪酯)的相互作用。在输注上述其中一种麻醉药期间,通过滴定法确定ED95剂量,此后用随后的四剂ORG 9426维持肌肉松弛。ORG 9426首剂以及维持剂量的效能和作用持续时间与腹腔注射戊巴比妥麻醉的猫对照组中观察到的情况均无差异。所有组的恢复率相似。作者得出结论,在本研究条件下,常用静脉麻醉药不太可能在任何显著程度上影响ORG 9426的神经肌肉阻滞效能和作用时程。